Medikamentöse Tumortherapie
Authors:
- Ulf PetrauschUPUlf Petrausch
- Andreas MüllerAMAndreas Müller
- Thomas KronerTKThomas Kroner
- 23 April 2024
- book chapter
- Published by Springer Nature
- p. 139-191
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaDrug Safety, 2018
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2017
- Cancer Immunotherapy Researchers Focus on Refining Checkpoint Blockade Therapies2015
- 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyondNature Reviews Molecular Cell Biology, 2014
- Factors associated with early progression of non‐small‐cell lung cancer treated by epidermal growth factor receptor tyrosine‐kinase inhibitorsCancer Medicine, 2014
- Grundlagen der Molekularen Medizin2008